Remdesivir News and Research

RSS

GlobalData: China can use the lessons learnt from SARS epidemic to control Wuhan coronavirus

Following the news that cases of people infected with the Wuhan coronavirus rose to more than 270 laboratory-confirmed cases and the virus may spread from human-to-human.

22 Jan 2020

Experimental therapies offer patients a greater chance of surviving Ebola virus disease

The investigational therapeutics mAb114 and REGN-EB3 offer patients a greater chance of surviving Ebola virus disease compared to the investigational treatment ZMapp, according to published results from a clinical trial conducted in the Democratic Republic of the Congo.

2 Dec 2019

Experimental antiviral drug completely protects monkeys from Nipah virus

The experimental antiviral drug remdesivir completely protected four African green monkeys from a lethal dose of Nipah virus, according to a new study in Science Translational Medicine from National Institutes of Health scientists and colleagues.

29 May 2019

Study provides framework for developing Ebola virus therapeutic under FDA Animal Rule

The U.S. Army Medical Research Institute of Infectious Diseases today announced that, for the first time, the U.S. Food and Drug Administration has provided formal regulatory agreement for use of an animal model to support development of a drug candidate, remdesivir, for treating deadly Ebola virus infections.

29 Mar 2019

At-risk healthcare workers being vaccinated against Ebola in Uganda

Healthcare workers in Uganda have begun vaccinating high risk health workers against the deadly viral infection Ebola this week. This is the first time that a vaccination drive has begun before the actual outbreak.

7 Nov 2018

Grim updates on Ebola outbreak in Congo

According to the health ministry, there have been five new cases of Ebola and five deaths from haemmorhagic fever. Ebola cases now sum up at 96 (5 new cases) from the town of Mabalako-Mangina. A total of 69 are confirmed. 55 people have died.

22 Aug 2018